PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Nanosonics Limited (NAN.AX)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

AU000000NAN9

Sector

Healthcare

IPO Date

May 15, 2007

Highlights

Market Cap

A$1.01B

EPS (TTM)

A$0.04

PE Ratio

83.25

Total Revenue (TTM)

A$90.37M

Gross Profit (TTM)

A$68.99M

EBITDA (TTM)

A$12.60M

Year Range

A$2.59 - A$3.97

Target Price

A$3.56

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of A$10,000 in Nanosonics Limited, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%10.00%20.00%30.00%SeptemberOctoberNovemberDecember2025February
20.85%
16.22%
NAN.AX (Nanosonics Limited)
Benchmark (^GSPC)

Returns By Period

Nanosonics Limited had a return of 13.62% year-to-date (YTD) and 17.12% in the last 12 months. Over the past 10 years, Nanosonics Limited had an annualized return of 6.78%, while the S&P 500 had an annualized return of 11.32%, indicating that Nanosonics Limited did not perform as well as the benchmark.


NAN.AX

YTD

13.62%

1M

5.23%

6M

22.14%

1Y

17.12%

5Y*

-14.85%

10Y*

6.78%

^GSPC (Benchmark)

YTD

3.97%

1M

4.66%

6M

10.32%

1Y

22.29%

5Y*

12.63%

10Y*

11.32%

*Annualized

Monthly Returns

The table below presents the monthly returns of NAN.AX, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202514.62%13.62%
2024-32.27%-8.39%0.73%6.18%-3.77%6.41%5.35%2.54%14.24%-13.28%1.88%-7.67%-31.59%
202312.59%-6.00%12.11%11.98%-11.93%-5.58%-0.21%-11.42%0.72%-11.61%16.09%1.62%2.56%
2022-19.49%-17.52%-5.01%1.01%-4.73%-12.27%40.18%-12.53%-16.02%18.79%15.33%-9.49%-32.01%
2021-14.82%-11.84%-5.47%5.79%-7.96%5.77%-9.54%24.67%-4.68%-6.18%-7.77%15.57%-21.42%
20209.29%-3.46%-16.42%23.39%4.63%-5.67%-9.24%-2.10%-6.27%-9.33%29.32%20.57%26.46%
201917.61%24.25%5.06%13.30%-8.91%24.89%-1.96%21.05%-5.40%7.77%-1.91%-4.80%123.59%
20182.17%-6.36%-3.02%-6.23%10.37%18.80%-0.00%11.39%1.99%-16.43%4.33%-9.27%2.53%
2017-7.40%-0.35%8.01%1.94%-10.76%-9.93%-7.09%10.59%0.00%14.94%-15.33%9.06%-10.93%
20163.51%-2.87%7.53%11.00%8.56%-9.13%25.11%13.87%8.65%2.36%-3.17%-7.44%68.11%
2015-1.46%31.11%7.34%-13.68%8.84%-4.76%5.59%-25.35%-1.49%21.21%-2.81%18.97%35.04%
20144.76%-9.09%7.50%-5.81%-9.26%7.48%5.70%8.98%8.79%-1.52%8.21%29.86%63.10%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of NAN.AX is 56, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of NAN.AX is 5656
Overall Rank
The Sharpe Ratio Rank of NAN.AX is 5858
Sharpe Ratio Rank
The Sortino Ratio Rank of NAN.AX is 5353
Sortino Ratio Rank
The Omega Ratio Rank of NAN.AX is 5353
Omega Ratio Rank
The Calmar Ratio Rank of NAN.AX is 5656
Calmar Ratio Rank
The Martin Ratio Rank of NAN.AX is 6161
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Nanosonics Limited (NAN.AX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for NAN.AX, currently valued at 0.32, compared to the broader market-2.000.002.004.000.321.69
The chart of Sortino ratio for NAN.AX, currently valued at 0.80, compared to the broader market-6.00-4.00-2.000.002.004.006.000.802.29
The chart of Omega ratio for NAN.AX, currently valued at 1.11, compared to the broader market0.501.001.502.001.111.31
The chart of Calmar ratio for NAN.AX, currently valued at 0.22, compared to the broader market0.002.004.006.000.222.57
The chart of Martin ratio for NAN.AX, currently valued at 1.38, compared to the broader market0.0010.0020.0030.001.3810.46
NAN.AX
^GSPC

The current Nanosonics Limited Sharpe ratio is 0.32. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Nanosonics Limited with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00SeptemberOctoberNovemberDecember2025February
0.32
2.11
NAN.AX (Nanosonics Limited)
Benchmark (^GSPC)

Dividends

Dividend History


Nanosonics Limited doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2025February
-58.55%
-1.01%
NAN.AX (Nanosonics Limited)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Nanosonics Limited. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Nanosonics Limited was 81.10%, occurring on Oct 8, 2008. Recovery took 505 trading sessions.

The current Nanosonics Limited drawdown is 58.55%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-81.1%May 18, 2007355Oct 8, 2008505Oct 6, 2010860
-68.12%Jan 5, 2021795Feb 26, 2024
-58.76%Mar 1, 2011550May 6, 2013336Sep 1, 2014886
-43.02%Feb 17, 202026Mar 23, 2020191Dec 18, 2020217
-38.23%Mar 25, 2015112Sep 1, 2015117Feb 16, 2016229

Volatility

Volatility Chart

The current Nanosonics Limited volatility is 11.42%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


5.00%10.00%15.00%20.00%SeptemberOctoberNovemberDecember2025February
11.42%
3.49%
NAN.AX (Nanosonics Limited)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Nanosonics Limited over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Valuation

The Valuation section provides an assessment of the market value of Nanosonics Limited compared to its peers in the Medical Instruments & Supplies industry.


PE Ratio
50.0100.0150.0200.083.3
The chart displays the price to earnings (P/E) ratio for NAN.AX in comparison to other companies of the Medical Instruments & Supplies industry. Currently, NAN.AX has a PE value of 83.3. This PE ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.
PEG Ratio
0.05.010.015.020.00.0
The chart displays the price to earnings to growth (PEG) ratio for NAN.AX in comparison to other companies of the Medical Instruments & Supplies industry. Currently, NAN.AX has a PEG value of 0.0. This PEG ratio falls in the average range for the industry.

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Nanosonics Limited.


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab